AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.50 Decreased By ▼ -0.03 (-0.02%)
BOP 6.76 Increased By ▲ 0.08 (1.2%)
CNERGY 4.46 Decreased By ▼ -0.17 (-3.67%)
DCL 8.60 Decreased By ▼ -0.34 (-3.8%)
DFML 40.90 Decreased By ▼ -0.79 (-1.89%)
DGKC 81.00 Decreased By ▼ -2.77 (-3.31%)
FCCL 32.85 Increased By ▲ 0.08 (0.24%)
FFBL 74.89 Decreased By ▼ -0.58 (-0.77%)
FFL 11.68 Increased By ▲ 0.21 (1.83%)
HUBC 109.30 Decreased By ▼ -1.25 (-1.13%)
HUMNL 13.83 Decreased By ▼ -0.73 (-5.01%)
KEL 5.37 Decreased By ▼ -0.02 (-0.37%)
KOSM 7.87 Decreased By ▼ -0.53 (-6.31%)
MLCF 39.03 Decreased By ▼ -0.76 (-1.91%)
NBP 63.75 Increased By ▲ 3.46 (5.74%)
OGDC 197.00 Decreased By ▼ -2.66 (-1.33%)
PAEL 25.81 Decreased By ▼ -0.84 (-3.15%)
PIBTL 7.47 Decreased By ▼ -0.19 (-2.48%)
PPL 156.10 Decreased By ▼ -1.82 (-1.15%)
PRL 26.04 Decreased By ▼ -0.69 (-2.58%)
PTC 17.50 Decreased By ▼ -0.96 (-5.2%)
SEARL 79.00 Decreased By ▼ -3.44 (-4.17%)
TELE 7.80 Decreased By ▼ -0.51 (-6.14%)
TOMCL 33.88 Decreased By ▼ -0.63 (-1.83%)
TPLP 8.54 Decreased By ▼ -0.52 (-5.74%)
TREET 16.60 Decreased By ▼ -0.87 (-4.98%)
TRG 58.30 Decreased By ▼ -3.02 (-4.92%)
UNITY 27.69 Increased By ▲ 0.26 (0.95%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 10,490 Increased By 83.2 (0.8%)
BR30 31,358 Decreased By -355.2 (-1.12%)
KSE100 98,080 Increased By 751.3 (0.77%)
KSE30 30,543 Increased By 350.3 (1.16%)
World

WHO's COVAX initiative aims to start shipping 90mn COVID-19 vaccine doses to Africa in Feb

  • The roll-out of the AstraZeneca-Oxford vaccine is subject to the vaccine being listed for emergency use by WHO.
Published February 5, 2021

The World Health Organization said on Thursday its COVAX initiative aims to start shipping nearly 90 million COVID-19 vaccine doses to Africa in February.

About 320,000 doses of the Pfizer-BioNTech vaccine have been allocated to four African countries - Cabo Verde, Rwanda, South Africa and Tunisia, the WHO said in a statement.

The roll-out of the AstraZeneca-Oxford vaccine is subject to the vaccine being listed for emergency use by WHO.

The organization is currently reviewing the vaccine and the outcome of the review is expected soon.

Comments

Comments are closed.